PKBO — Peak Bio Cashflow Statement
0.000.00%
- $0.22m
- $4.24m
- $0.61m
Annual cashflow statement for Peak Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Net Income/Starting Line | -13.3 | -8.29 | -13.1 |
Depreciation | |||
Non-Cash Items | 1.03 | -0.841 | 3.08 |
Unusual Items | |||
Other Non-Cash Items | |||
Changes in Working Capital | 0.519 | 0.093 | 2.37 |
Change in Accounts Receivable | |||
Change in Prepaid Expenses | |||
Change in Other Assets | |||
Change in Accounts Payable | |||
Change in Accrued Expenses | |||
Change in Other Liabilities | |||
Cash from Operating Activities | -11.6 | -8.86 | -7.49 |
Capital Expenditures | -0.341 | -0.01 | -0.142 |
Purchase of Fixed Assets | |||
Cash from Investing Activities | -0.341 | -0.01 | -0.142 |
Financing Cash Flow Items | 12.3 | 6.39 | 1.36 |
Other Financing Cash Flow | |||
Net Issuance / Retirement of Stock | |||
Net Issuance / Retirement of Debt | |||
Cash from Financing Activities | 12.7 | 8.38 | 8.14 |
Foreign Exchange Effects | |||
Beginning Cash Balance | |||
Ending Cash Balance | |||
Net Change in Cash | 0.239 | 0.033 | 0.452 |